3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
22
Prostatic Neoplasms, Castration-Resistant
6
Neoplasm Metastasis
4
Breast Neoplasms
3
Neoplasms
2
Multiple Myeloma
2
Metastatic Castration-resistant Prostate Cancer
2
Hormone Refractory Prostate Cancer
2
Bone Metastatic Castration-resistant Prostate Cancer
2
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castration Resistant Prostate Cancer (mCRPC)
1
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
1
Fractures, Bone
1
Castration-resistant Prostate Cancer
1
Castrate-Resistant Prostate Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Bone Neoplasms
1
Bone Metastases
1
Bone Diseases
1
Interventions
Zoledronic Acid
4
Denosumab
4
Toremifene
2
radium Ra 223 dichloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Fractures, Bone
×
radium Ra 223 dichloride
×
Clear all
NCT04256993
2024-01-16
PRECISE
Bayer
Completed
1,434 enrolled